Clinical Trials on Peripheral Obliterative Arteriopathy in Australia

Total 338 results

Medical University of Graz

Completed

Revascularisation of Autotransplanted Teeth

Endodontic Disease | Pulp Canal Obliteration

Austria
Alucent Biomedical

Active, not recruiting

Feasibility Study of the Vessel Restoration System (VRS): ACTIVATE II (ACTIVATEII)

PAD - Peripheral Arterial Disease

Australia
Alucent Biomedical

Active, not recruiting

Feasibility Study of the Vessel Restoration System (VRS) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Popliteal Artery (PA) After Sub-optimal Percutaneous Transluminal Angioplasty (PTA) or Atherectomy: REACTIVATE I (REACTIVATE I)

PAD - Peripheral Arterial Disease

Australia
Biotronik CRC Inc.
Biotronik AG

Completed

BRight DCB First-in-Human Study

Peripheral Artery Disease

New Zealand, Australia, Germany, Austria
Sonnet BioTherapeutics

Terminated

SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN)

Chemotherapy-induced Peripheral Neuropathy (CIPN)

Australia
SIMR (Australia) Biotech Pty Ltd.

Completed

A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419

Peripheral Neuropathic Pain

Australia
Flinders University
The Queen Elizabeth Hospital; Flinders Medical Centre; Royal Adelaide Hospital

Completed

Effect of Exercise Training on Protein Expression in Skeletal Muscle Tissue After Exercise in Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Biotronik CRC Inc.

Recruiting

BRight Pharmacokinetic Study

Peripheral Artery Disease

Australia
Actinogen Medical
ICON plc

Completed

Xanamem™ in Healthy Elderly Subjects (XanaHES)

Cognitive Function | Peripheral Neuropathy | Electrocardiography | Central Nervous System | Safety | Healthy Ageing | Cortisol | Cerebrospinal Fluid | Small Fibre Neuropathy

Australia
Monash University
Monash Health

Recruiting

Carnosine for Peripheral Vascular Disease (Car-PVD)

Peripheral Arterial Disease

Australia
Biotronik AG

Active, not recruiting

BIO REsponse Adapted Combination Therapy Pilot Study

Peripheral Arterial Disease

Australia, Belgium, France, Germany, Austria, Spain
Bayside Health

Completed

Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Baker Heart Research Institute

Completed

The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Bayside Health
National Health and Medical Research Council, Australia

Terminated

Effects of Niacin on Good Cholesterol in People With Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Amplitude Vascular Systems, Inc.

Active, not recruiting

POWER: Pulse Intravascular Lithotripsy (Pulse IVL) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling (POWER-PAD-1)

Peripheral Arterial Disease

Australia, New Zealand, Dominican Republic
SurModics, Inc.

Completed

Safety and Feasibility of Surmodics SUNDANCE™ Drug Coated Balloon (SWING)

Peripheral Arterial Disease | Critical Lower Limb Ischemia

New Zealand, Australia, Austria, Germany, Latvia
Lateral Pharma Pty Ltd
Southern Star Research Pty Ltd.

Completed

A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain

Radiculopathy Lumbar

Australia
C. R. Bard

Active, not recruiting

Study of BD Sirolimus Drug Coated Catheter for Treatment of Femoropopliteal Arteries (PREVISION)

Peripheral Arterial Disease | Peripheral Artery Disease | Stenosis Artery

Australia, New Zealand, Singapore
Symic Vascular
Symic Biomedical, Inc.

Unknown

Angioplasty + SBCV vs. Angioplasty Alone for Femoropopliteal Artery Stenosis (SHIELD)

Peripheral Arterial Disease

Australia, New Zealand
Tremeau Pharmceuticals, Inc.

Terminated

Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy (RESET-HA)

Hemophilic Arthropathy

United States, Italy, Turkey, Spain, Australia, Canada, Ukraine, Poland
Monash University
Novartis Pharmaceuticals

Recruiting

VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN) (v-ASCERTAIN)

Cerebrovascular Disease | Coronary Heart Disease (CHD) | Peripheral Arterial Disease (PAD) | Atherosclerotic Cardiovascular Disease (ASCVD)

Australia
Vienna Hospital Association

Completed

High Tone Therapy for Chemotherapy Induced Neuropathy

Electrical Stimulation | Chemotherapy-induced Peripheral Neuropathy

Austria
Shockwave Medical, Inc.

Completed

Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System (Disrupt PAD+)

Peripheral Arterial Disease | Vascular Disease, Peripheral

New Zealand, Australia, United States
Vienna Hospital Association

Recruiting

The Mamma HiToP Study

Chemotherapy-induced Peripheral Neuropathy

Austria
University of Adelaide

Unknown

Minocycline for the Prevention of Post-operative Intercostal Neuralgia

Post-operative Intercostal Neuralgia

Australia
Biogen

Completed

Evaluate the Safety, Tolerability and Pharmacokinetics of BG00010 (Neublastin) Administered to Sciatica Participants

Sciatica

Australia
Shockwave Medical, Inc.

Active, not recruiting

Mini S Feasibility Study With Shockwave Medical Mini S Peripheral IVL System

Peripheral Arterial Disease

New Zealand, Australia
Medical University of Graz

Completed

Concepts for Analgosedation During Placement of Regional Anaesthesia Before Operations.

Fractures, Closed | Hip Arthritis | Knee Arthropathy

Austria
Efemoral Medical, Inc.

Recruiting

The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery (Efemoral I)

Vascular Diseases | Peripheral Arterial Disease | Stenosis | Femoropopliteal Stenosis

New Zealand, Australia
Medical University of Vienna

Unknown

Exercise Training Versus Best Medical Treatment Only in Peripheral Artery Disease

Peripheral Artery Disease

Austria
Baker Heart and Diabetes Institute

Terminated

The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication

Peripheral Arterial Disease | Intermittent Claudication

Australia
Cook Group Incorporated

Completed

Zilver PTX Delivery System

Peripheral Vascular Disease

New Zealand, Australia, Germany
Becton, Dickinson and Company
Griffith University

Completed

Impact of PIVC Length and Gauge on Catheter Indwell Time

Indication for Peripheral Intravenous Catheterisation

Australia
Ludwig Boltzmann Gesellschaft

Recruiting

Extracorporal Shock Wave Treatment to Improve Nerve Regeneration

Peripheral Nerve Injury

Austria
Medical University Innsbruck

Recruiting

Cryotherapy vs. Cryocompression for Preventing Chemotherapy-induced-peripheral-neuropathy in Women Undergoing Chemotherapy

Chemotherapeutic Toxicity | Chemotherapy-induced Peripheral Neuropathy | Chemotherapeutic Agent Toxicity

Austria
Royal Brisbane and Women's Hospital

Unknown

Peripheral Venous Catheter Trial: 3 Day Versus No Routine Change

Phlebitis

Australia
Vienna General Hospital

Completed

PTA vs. Primary Stenting of SFA Using Self-Expandable Nitinol Stents

Peripheral Vascular Diseases | Intermittent Claudication | Angioplasty

Austria
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer

Chemotherapy-Induced Peripheral Neuropathy

Australia, Germany, Italy, Spain, Korea, Republic of, Taiwan
Corindus Inc.

Completed

Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease II (RAPID II)

Peripheral Arterial Disease

Austria
Hoffmann-La Roche

Completed

A Multiple Ascending Dose Study of RO4905417 in Healthy Volunteers and Patients With Peripheral Arterial Disease (PAD).

Peripheral Arterial Disease (PAD)

United States, Canada, Australia
Philips Clinical & Medical Affairs Global

Completed

Tack Optimized Balloon Angioplasty Below the Knee (TOBA - BTK) Study (TOBABTK)

Peripheral Artery Disease | Critical Limb Ischemia

Austria
Guerbet

Completed

Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease (DALIA)

Peripheral Arterial Disease

Austria
Sanofi
Bristol-Myers Squibb

Completed

CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease

Arterial Occlusive Diseases

France, Spain, Italy, Belgium, Germany, Hungary, Poland, Australia, Austria, Netherlands, Sweden, United Kingdom, Finland, Switzerland
Medical University Innsbruck

Recruiting

Mitochondrial Function in Peripheral Arterial Disease (MIVA)

Cardiovascular Diseases | Peripheral Arterial Disease

Austria
Medical University of Vienna

Unknown

Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT) (NASCIT)

Atherosclerosis | Dyslipidemia

Austria
AstraZeneca
Pretium Pty Ltd

Completed

Audit and Screening Study to Determine the Prevalence of Peripheral Arterial Disease (ACHILLES)

Peripheral Arterial Disease

Australia
Medical University of Graz
AIT Austrian Institute of Technology GmbH

Completed

A Usability Study of a Tele-health Service for Patients With Peripheral Arterial Disease.

Peripheral Arterial Disease

Austria
The University of New South Wales

Terminated

The ABSORB Bioresorbable Scaffold Below the Knee (BTK) Study

Ischemia | Arterial Occlusive Diseases | Peripheral Arterial Disease (PTA

New Zealand, Australia, Netherlands
iN Therapeutics Co., Ltd.

Recruiting

A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.

Pain | Osteoarthritis | Chronic Pain | Neuropathic Pain | Post Herpetic Neuralgia

Australia
Xalud Therapeutics, Inc.

Terminated

Safety and Efficacy of XT-150 for Treatment of Neuropathic Pain

Neuropathic Pain

Australia

Clinical Trials on Peripheral Obliterative Arteriopathy in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations